Related Experiment Video
Updated: Mar 22, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Prevalence and Severity of Anemia in Children Hospitalized with Acute Heart Failure
Jason F Goldberg1, Mona D Shah1, Paul F Kantor2
1Baylor College of Medicine, Houston, Tex, USA.
Insights
Anemia is common in pediatric acute heart failure patients, affecting 38% before adverse outcomes. Lower hemoglobin levels significantly increase the risk of mortality, mechanical support, or transplantation in these children.
Area of Science:
- Pediatric Cardiology
- Hematology
- Critical Care Medicine
Background:
- Anemia is prevalent in adult heart failure patients, linked to poor outcomes.
- Limited data exist on anemia prevalence and its impact in pediatric heart failure.
Purpose of the Study:
- To determine the prevalence of anemia in children hospitalized with acute heart failure.
- To evaluate the association between anemia and adverse outcomes in this population.
Main Methods:
- Retrospective review of 172 hospitalizations for acute heart failure in children (2007-2012).
- Data collected included patient demographics, heart failure etiology, and hemoglobin levels.
- Adverse outcomes defined as a composite endpoint of death, mechanical circulatory support, or cardiac transplantation.
Main Results:
- Anemia was present in 18% of admissions and 38% before adverse outcomes.
- Anemia was associated with a significantly increased risk of death, transplantation, or mechanical support (aOR 1.79).
- Each 1 g/dL increase in lowest hemoglobin reduced the odds of adverse outcomes by 18% (aOR 0.82).
Conclusions:
- Anemia is a common comorbidity in children hospitalized with acute heart failure.
- Anemia is significantly associated with increased risk of mortality, mechanical circulatory support, and cardiac transplantation.
- Addressing anemia may be crucial for improving outcomes in pediatric heart failure.
Objective:
Anemia is common among adult heart failure patients and is associated with adverse outcomes, but data are lacking in children with heart failure. The purpose of this study was to determine the prevalence of anemia in children hospitalized with acute heart failure and to evaluate the association between anemia and adverse outcomes.
Design:
Review of the medical records of 172 hospitalizations for acute heart failure.
Setting:
Single, tertiary children's hospital.
Patients:
All acute heart failure admissions to our institution from 2007 to 2012.
Interventions:
None.
Outcome Measures:
Composite endpoint of death, mechanical circulatory support deployment, or cardiac transplantation.
Results:
Patients ages ranged in age from 4 months to 23 years, with a median of 7.5 years, IQR 1.2, 15.9. Etiologies of heart failure included: dilated cardiomyopathy (n = 125), restrictive cardiomyopathy (n = 16), transplant coronary artery disease (n = 18), ischemic cardiomyopathy (n = 7), and heart failure after history of congenital heart disease (n = 6). Mean hemoglobin concentration at admission was 11.8 g/dL (±2.0 mg/dL). Mean lowest hemoglobin prior to outcome was 10.8 g/dL (±2.2 g/dL). Anemia (hemoglobin <10 g/dL) was present in 18% of hospitalizations at admission and in 38% before outcome. Anemia was associated with increased risk of death, transplant, or mechanical circulatory support deployment (adjusted odds ratio 1.79, 95% confidence interval = 1.12-2.88, P = .011). For every 1 g/dL increase in the patients' lowest hemoglobin during admission, the odds of death, transplant, or mechanical circulatory support deployment decreased by 18% (adjusted odds ratio = 0.82, 95% confidence interval = 0.74-0.93, P = 0.002).
Conclusions:
Anemia occurs commonly in children hospitalized for acute heart failure and is associated with increased risk of transplant, mechanical circulatory support, and inhospital mortality.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure VII: Nursing Interventions
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology

